Matches in DBpedia 2014 for { <http://dbpedia.org/resource/SemBioSys_Genetics> ?p ?o. }
Showing items 1 to 48 of
48
with 100 items per page.
- SemBioSys_Genetics abstract "SemBioSys Genetics Inc. was a development stage agricultural biotechnology company. It utilized its patented safflower pharming platform to develop and make proteins and oils for the nutraceutical, functional food and beverage, and pharmaceutical industries. A University of Calgary spin-off (1994), SemBioSys became a publicly traded firm. Investors had included Bay City Capital, the Business Development Bank of Canada, Dow AgroSciences (a Canadian subsidiary of The Dow Chemical Company), Royal Bank Ventures Inc. (now RBC Capital Partners), the University of Calgary, Ventures West Capital Ltd., and Dr. Maurice Moloney. In May 2012, SemBioSys terminated its operations.The company's strategy was to partner with other companies to enable the commercialization of products. Its lead pharmaceutical products under development were biosimilar insulin and Apo AI(Milano). In a phase I/II clinical trial, SemBioSys demonstrated that its safflower produced insulin (SBS-1000) is bioequivalent to Humulin(R), a commercially available insulin.In 2007, SemBioSys formed a subsidiary, Botaneco Specialty Ingredients Inc., dedicated to the commercialization of SemBioSys’ products for cosmetic, personal care and prescription topical dermatology products. Botaneco produced, marketed, and sold its products under the brand name Hydresia. In October 2009, Botaneco merged with Quebec Ciy-based Advitech, a health sciences and technology company.In October 2011, SemBioSys signed a collaboration agreement with Tasly Pharmaceuticals, Ltd. of Tianjin, China and its wholly owned subsidiary Tasly U.S. Tasly is of China’s top five largest producers of traditional Chinese medicines (TCMs). Upon government approval, a new company called Tasly-SemBioSys Bio-Pharmaceuticals Co., Ltd. was incorporated in Tianjin, China. The new company was structured as a Sino-Foreign Equity Joint Venture and seeks to develop and commercialize a variety of products including pharmaceutical, functional foods, and nutraceuticals for China and the world. However SemBioSys did not transfer any intellectual property to the joint venture and Tasly terminated the agreement.".
- SemBioSys_Genetics industry Biotechnology.
- SemBioSys_Genetics locationCity Calgary.
- SemBioSys_Genetics locationCountry Canada.
- SemBioSys_Genetics numberOfEmployees "20".
- SemBioSys_Genetics type Public_company.
- SemBioSys_Genetics wikiPageExternalLink www.sembiosys.com.
- SemBioSys_Genetics wikiPageExternalLink index.aspx.
- SemBioSys_Genetics wikiPageID "4369174".
- SemBioSys_Genetics wikiPageRevisionID "562917287".
- SemBioSys_Genetics hasPhotoCollection SemBioSys_Genetics.
- SemBioSys_Genetics homepage www.sembiosys.com.
- SemBioSys_Genetics industry "Biotechnology".
- SemBioSys_Genetics keyPeople "James Szarko, President and CEO".
- SemBioSys_Genetics locationCity Calgary.
- SemBioSys_Genetics locationCountry Canada.
- SemBioSys_Genetics name "SemBioSys Genetics Inc.".
- SemBioSys_Genetics numEmployees "Approximately 20".
- SemBioSys_Genetics type Public_company.
- SemBioSys_Genetics subject Category:Biotechnology_companies_of_Canada.
- SemBioSys_Genetics type Abstraction100002137.
- SemBioSys_Genetics type BiotechnologyCompaniesOfCanada.
- SemBioSys_Genetics type Company108058098.
- SemBioSys_Genetics type Group100031264.
- SemBioSys_Genetics type Institution108053576.
- SemBioSys_Genetics type Organization108008335.
- SemBioSys_Genetics type SocialGroup107950920.
- SemBioSys_Genetics type YagoLegalActor.
- SemBioSys_Genetics type YagoLegalActorGeo.
- SemBioSys_Genetics type YagoPermanentlyLocatedEntity.
- SemBioSys_Genetics type Agent.
- SemBioSys_Genetics type Company.
- SemBioSys_Genetics type Organisation.
- SemBioSys_Genetics type Organization.
- SemBioSys_Genetics type Business.
- SemBioSys_Genetics type Agent.
- SemBioSys_Genetics type SocialPerson.
- SemBioSys_Genetics type Thing.
- SemBioSys_Genetics comment "SemBioSys Genetics Inc. was a development stage agricultural biotechnology company. It utilized its patented safflower pharming platform to develop and make proteins and oils for the nutraceutical, functional food and beverage, and pharmaceutical industries. A University of Calgary spin-off (1994), SemBioSys became a publicly traded firm.".
- SemBioSys_Genetics label "SemBioSys Genetics".
- SemBioSys_Genetics sameAs m.0bzlhy.
- SemBioSys_Genetics sameAs Q7448968.
- SemBioSys_Genetics sameAs Q7448968.
- SemBioSys_Genetics sameAs SemBioSys_Genetics.
- SemBioSys_Genetics wasDerivedFrom SemBioSys_Genetics?oldid=562917287.
- SemBioSys_Genetics homepage www.sembiosys.com.
- SemBioSys_Genetics isPrimaryTopicOf SemBioSys_Genetics.
- SemBioSys_Genetics name "SemBioSys Genetics Inc.".